Trial Profile
A Multicenter, Double-Blind, Randomized, Parallel-Group Study Investigating the Clinical Effect of Montelukast in Patients With Seasonal Allergic Rhinitis-Fall Study.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 05 May 2022
Price :
$35
*
At a glance
- Drugs Montelukast (Primary) ; Loratadine
- Indications Seasonal allergic rhinitis
- Focus Therapeutic Use
- Sponsors Merck Sharp & Dohme Corp.
- 25 Aug 2009 New trial record